SEC Filings for Portola Pharmaceuticals Inc. (PTLA)

$ 17.925   0.065 (+0.36%) Volume: 533.31k 10:48 AM EDT Jun 2, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
SC 14D9/A[Amend] Solicitation, recommendation statements306/01/2020
SC TO-T/A[Amend] Tender offer statement by Third Party1306/01/2020
SC 14D9Solicitation, recommendation statements6705/27/2020
SC TO-TTender offer statement by Third Party12705/27/2020
SC14D9CWritten communication relating to third party tender offer1105/26/2020
DEFA14AAdditional proxy soliciting materials - definitive305/18/2020
8-KCurrent report pursuant to Section 13 or 15(d)905/11/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)7105/11/2020
SC 13DGeneral statement of acquisition of beneficial ownership1505/08/2020
SC14D9CWritten communication relating to third party tender offer205/07/2020
SC TO-CWritten communication relating to an issuer or third party10805/07/2020
8-KCurrent report pursuant to Section 13 or 15(d)13705/07/2020
SC14D9CWritten communication relating to third party tender offer1605/07/2020
SC TO-CWritten communication relating to an issuer or third party1605/07/2020
SC TO-CWritten communication relating to an issuer or third party1105/06/2020
<<
First
<
Prev
123456789101112131415